Mr Eran Yaniv > FISCHER (FBC & Co.) > Tel Aviv, Israel > Lawyer Profile

TEL AVIV 6492103

Work Department

Hi-Tech; Technology & Venture Capital; Mergers & Acquisitions; Life Sciences & Health Care; Private Equity; Banking & Finance; Capital Markets


FBC – Eran Yaniv

Mr. Yaniv is a partner in FBC’s Corporate Department, acting for clients in a variety of cross-border corporate transactions with an emphasis on technology, life sciences and venture capital investments.

Mr. Yaniv has a particular expertise in hi-tech and complex international transactions, including mergers and acquisitions and public offerings. He is involved in the structuring and representation of venture capital, mezzanine, and hedge funds operating in Israel and the United States, and has significant experience in restructuring, debt financing, and spin-offs. He regularly advises public and private companies on strategic collaborations, technology licensing, and securities issuances.

Mr. Yaniv serves as the Co-Chairman of the Corporate Committee of the Tel Aviv District of the Israel Bar Association.

Mr. Yaniv lectures as part of the graduate program in Business Management at the Interdisciplinary Center Herzliya, and serves as the joint chairman of the Corporate Committee of the Israel Bar Association.


Hebrew, English


Israel Bar Association, 1998


Tel Aviv University (LL.B.), 1993

Lawyer Rankings

Israel > Capital markets

(Leading individuals)

Eran Yaniv– FISCHER (FBC & Co.) 

FISCHER (FBC & Co.)‘s team further consolidated its position in the market in January 2020 with the recruitment of the entire team from Sharir, Shiv & Co., including capital markets specialist Alex Berman. While the firm’s expertise across equity and debt is all-encompassing, the team truly stands out for its involvement in market first IPOs – on the issuer and underwriter side – and complex regulatory matters, including major investigations and disputes. Avraham Well‘s ongoing work includes advising REIT 1, Israel’s first publicly traded REIT, on public offerings of debt and a private placement of equity with a cumulative value of over $160m. Nitzan Sandor is a leading securities law specialist;  Eran Yaniv has impressive credentials on the underwriter side; and Boaz Noiman is also noted.

Israel > Investment and venture capital funds

Co-led by Raz Tepper and Eran Yaniv, the team at FISCHER (FBC & Co.) is noted for the broad range of clients it advises; the firm is instructed by private equity funds, venture capital funds, real estate funds and publicly traded funds. It also has a strong track record of advising on innovative matters within the fund formation and management space, having recently assisted Generation Capital with the establishment and structuring of the first infrastructure and energy fund to be listed on the Tel Aviv Stock Exchange.

Israel > Healthcare and life sciences

FISCHER (FBC & Co.)‘s team has a comprehensive offering in the area of healthcare and life sciences, which includes assisting with IP licensing, privacy and data protection, M&A, trade mark and patent disputes and competition law. Among recent work highlights, the firm represented several medical device companies (including Alpha-Bio Tech and Medici Medical) in complex class product liability claims. Raz Tepper is very active in various fields, including biopharmaceuticals, biotechnology and genomics. Eran Yaniv focuses on cross-border transactions in the life sciences and technology sectors.

Israel > Hi-tech and start-ups

FISCHER (FBC & Co.) is a true market leader in the hi-tech space, representing global technology companies, venture capital and private equity funds, and innovative start-ups in a range of transactions. The team was significantly strengthened in January 2020 when the firm recruited the entire team of Sharir, Shiv & Co.. The new arrivals include Yoram Shiv and Alex Berman, both of whom have extensive experience in the hi-tech space. Eran Yaniv and Raz Tepper co-lead the technology practice; the former recently assisted ECI Telecom in its $485m sale to Ribbon Communications, while the latter is particularly active in the life science sector.